Verified factor-similar pair

SLYV vs SYLD

These two ETFs meet the same FF6 US comparison criteria: US-listed equity ETFs, the same USD model basis, at least one material non-market factor, and 100% overlap in statistically significant material factor exposure.

SMB HML RMW
Similarity score
88
Verified similar

The score combines exposure-level distance, factor-vector shape, market-beta closeness, and a small backtested relative-Sharpe term.

Quick Read

  • SYLD has the higher backtested relative Sharpe (1.245 vs 1.104).
  • SLYV has the lower published fee (0.15% vs 0.59%).
  • SLYV is cheaper on dividend valuation (127 vs 128, where 100 is each fund's historical median).
  • SLYV has the stronger regression fit (adjusted R-squared 0.957 vs 0.888).

These are screening signals, not a complete review of portfolio construction, turnover, taxes, or trading quality.

SLYV

State Street SPDR S&P 600 Small Cap Value ETF
SMB HML RMW
Adj. R2
0.957
Rel. Sharpe
1.104
Mkt beta
0.98
AUM
US$4.2B
MER
0.15%
Valuation
127

SYLD

Cambria Shareholder Yield ETF
SMB HML RMW
Adj. R2
0.888
Rel. Sharpe
1.245
Mkt beta
1.02
AUM
US$922M
MER
0.59%
Valuation
128

Factor Exposure Match

Blue bars compare raw factor beta magnitude. Green bars compare absolute t-stat strength. Dim bars indicate the t-stat is below 1.96.

SMB
SLYV
+0.80
|t|
+28.4
SYLD
+0.60
|t|
+8.9
diff +0.20
HML
SLYV
+0.39
|t|
+13.2
SYLD
+0.37
|t|
+5.7
diff +0.02
RMW
SLYV
+0.24
|t|
+7.3
SYLD
+0.25
|t|
+3.2
diff -0.02
CMA
SLYV
+0.09
|t|
+2.1
SYLD
+0.19
|t|
+2.0
diff -0.10
UMD
SLYV
-0.03
|t|
-1.9
SYLD
+0.00
|t|
+0.1
diff -0.04

Why This Pair Matches

Exposure level
86
Exposure shape
99
Mkt beta diff
0.04
Rel. Sharpe diff
0.141

This comparison focuses on measured factor exposure. It does not compare holdings methodology, turnover, tax handling, or issuer process. Backtested relative Sharpe is a secondary signal rather than a stand-alone forecast. See methodology.

SLYV fund page SYLD fund page US ETF Leaders US Universe
Important context

VerifiedBeta publishes educational ETF research, not personalized investment advice, portfolio management, or security recommendations. Funds that screen well here can still be unsuitable for your objectives, taxes, liquidity needs, or constraints. Review fund documents, methodology assumptions, and your own circumstances before acting. See the full disclaimer.